{"brief_title": "Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1", "brief_summary": "The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form.\"", "detailed_description": "1) Compare subjects response to liquid vs tablet formulation 2) Assess bioequivalency of liquid vs tablet 3)Compare subject preference 4) Evaluate if dose response curve for tablet = to liquid form", "condition": "Opioid-Related Disorders", "intervention_type": "Drug", "intervention_name": "Buprenorphine formulation: liquid vs. tablet", "description": "random assignment to liquid buprenorphine or tablet buprenorphine", "arm_group_label": "2; tablet formulation", "other_name": "Suboxone", "criteria": "Inclusion Criteria: M/F ages 18-65. Meet DMS-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent. Exclusion Criteria: Pregnant or nursing women. Acute medical condition that would interfere with study participation or put safety of subjects in jeopardy. Current daily use of anti-convulsants, antabuse or neuroleptics. DSM-IV diagnosis of ETOH or sedative/hypnotics dependence.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00000320.xml"}